AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
Apr 3, 2024
35599_dirs_2024-04-03_8077d0a2-ac06-4123-9455-48fc0ed1b9c6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-04-03
Reporting Person: Raykov Rosty (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-03 | Common shares | S | 14584 | $10.7782 | Disposed | 302054 | Direct |
| 2024-04-03 | Common shares | S | 26000 | $10.7793 | Disposed | 276054 | Direct |
Footnotes
F1: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023. Shares sold to satisy tax obligation.
F2: Represents shares sold pursuant to a 10b5-1 plan dated December 14, 2023.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20